arginyl-glycyl-aspartyl-serine

Known as: Arg-Gly-Asp-Ser, RGDS peptide, fibronectin tetrapeptide 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OligopeptidesPlatelet Aggregation Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
RGDS- and TAT-Conjugated Upconversion of NaYF4:Yb(3+)/Er(3+)&SiO2 Nanoparticles: In Vitro Human Epithelioid Cervix Carcinoma Cellular Uptake, Imaging, and Targeting.
Starting NaYF4:Yb(3+)/Er(3+) nanoparticles with size tuned from 24 to 33 nm were prepared by high-temperature coprecipitation of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
BACKGROUND AND AIM Fulminant hepatic failure (FHF) is a serious clinic syndrome with extremely poor prognosis and no effective… (More)
  • figure 2
Is this relevant?
2008
2008
99mTc-labeling and in vitro characterization of N4- and N3S-RGDS-derivative peptides
The aim of this work was to characterize the in vitro behavior of N4- and N3S-RGDS-derivative peptides labeled with 99mTc… (More)
Is this relevant?
1986
1986
Conditions for fibroblast adhesion without fibronectin.
Conditions that permit the adhesion of BHK fibroblasts to a variety of surfaces after inhibition of protein synthesis and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5-10
Is this relevant?